These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 30366804)

  • 1. Tracking donor funding towards achieving the Global Vaccine Action Plan (GVAP) goals: A landscape analysis (1990-2016).
    Ikilezi G; Zlavog B; Augusto OJ; Sherr K; Lim SS; Dieleman JL
    Vaccine; 2018 Nov; 36(49):7487-7495. PubMed ID: 30366804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of donor funding for immunization from Gavi and other development assistance channels on vaccine coverage: Evidence from 120 low and middle income recipient countries.
    Ikilezi G; Augusto OJ; Dieleman JL; Sherr K; Lim SS
    Vaccine; 2020 Jan; 38(3):588-596. PubMed ID: 31679863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustainability of National Immunization Programme (NIP) performance and financing following Global Alliance for Vaccines and Immunization (GAVI) support to the Democratic Republic of the Congo (DRC).
    Le Gargasson JB; Breugelmans JG; Mibulumukini B; Da Silva A; Colombini A
    Vaccine; 2013 Apr; 31(15):1886-91. PubMed ID: 23462529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspective and investments in health system strengthening of Gavi, the Vaccine Alliance: a content analysis of health system strengthening-specific funding.
    Tsai FJ; Lee H; Fan VY
    Int Health; 2016 Jul; 8(4):246-52. PubMed ID: 26612851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gavi's Transition Policy: Moving From Development Assistance To Domestic Financing Of Immunization Programs.
    Kallenberg J; Mok W; Newman R; Nguyen A; Ryckman T; Saxenian H; Wilson P
    Health Aff (Millwood); 2016 Feb; 35(2):250-8. PubMed ID: 26858377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Projections of costs, financing, and additional resource requirements for low- and lower middle-income country immunization programs over the decade, 2011-2020.
    Gandhi G; Lydon P; Cornejo S; Brenzel L; Wrobel S; Chang H
    Vaccine; 2013 Apr; 31 Suppl 2():B137-48. PubMed ID: 23598475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Charting the evolution of approaches employed by the Global Alliance for Vaccines and Immunizations (GAVI) to address inequities in access to immunization: a systematic qualitative review of GAVI policies, strategies and resource allocation mechanisms through an equity lens (1999-2014).
    Gandhi G
    BMC Public Health; 2015 Nov; 15():1198. PubMed ID: 26621528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costs of vaccine programs across 94 low- and middle-income countries.
    Portnoy A; Ozawa S; Grewal S; Norman BA; Rajgopal J; Gorham KM; Haidari LA; Brown ST; Lee BY
    Vaccine; 2015 May; 33 Suppl 1():A99-108. PubMed ID: 25919184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine Assistance To Low- And Middle-Income Countries Increased To $3.6 Billion In 2014.
    Haakenstad A; Birger M; Singh L; Liu P; Lim S; Ng M; Dieleman JL
    Health Aff (Millwood); 2016 Feb; 35(2):242-9. PubMed ID: 26858376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance-based financing with GAVI health system strengthening funding in rural Cambodia: a brief assessment of the impact.
    Matsuoka S; Obara H; Nagai M; Murakami H; Chan Lon R
    Health Policy Plan; 2014 Jul; 29(4):456-65. PubMed ID: 23735736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating total spending by source of funding on routine and supplementary immunisation activities in low-income and middle-income countries, 2000-17: a financial modelling study.
    Ikilezi G; Micah AE; Bachmeier SD; Cogswell IE; Maddison ER; Stutzman HN; Tsakalos G; Brenzel L; Dieleman JL
    Lancet; 2021 Nov; 398(10314):1875-1893. PubMed ID: 34742369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Updating the evidence base on the operational costs of supplementary immunization activities for current and future accelerated disease control, elimination and eradication efforts.
    Gandhi G; Lydon P
    BMC Public Health; 2014 Jan; 14():67. PubMed ID: 24450832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges to sustainable immunization systems in Gavi transitioning countries.
    Cernuschi T; Gaglione S; Bozzani F
    Vaccine; 2018 Oct; 36(45):6858-6866. PubMed ID: 30268735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Financial requirements of immunisation programmes in developing countries: a 2004-2014 perspective.
    Peny JM; Gleizes O; Covilard JP
    Vaccine; 2005 Aug; 23(37):4610-8. PubMed ID: 15979769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons learned in shaping vaccine markets in low-income countries: a review of the vaccine market segment supported by the GAVI Alliance.
    Gilchrist SA; Nanni A
    Health Policy Plan; 2013 Dec; 28(8):838-46. PubMed ID: 23174880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tracking progress towards universal childhood immunisation and the impact of global initiatives: a systematic analysis of three-dose diphtheria, tetanus, and pertussis immunisation coverage.
    Lim SS; Stein DB; Charrow A; Murray CJ
    Lancet; 2008 Dec; 372(9655):2031-46. PubMed ID: 19070738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring what governments "give for" and "spend on" vaccine procurement: Vaccine Procurement Assistance and Vaccine Procurement Baseline.
    Nelson EA; Bloom DE; Mahoney RT
    PLoS One; 2014; 9(2):e89593. PubMed ID: 24586899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applying lessons learned from the USAID family planning graduation experience to the GAVI graduation process.
    Shen AK; Farrell MM; Vandenbroucke MF; Fox E; Pablos-Mendez A
    Health Policy Plan; 2015 Jul; 30(6):687-95. PubMed ID: 24974106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The GAVI Alliance and the 'Gates approach' to health system strengthening.
    Storeng KT
    Glob Public Health; 2014; 9(8):865-79. PubMed ID: 25156323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What have we learned on costs and financing of routine immunization from the comprehensive multi-year plans in GAVI eligible countries?
    Brenzel L
    Vaccine; 2015 May; 33 Suppl 1():A93-8. PubMed ID: 25919183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.